COVID-19 Infection in 8 Big Cities of India: The Dynamics of the Spread and Seropositivity



Abstract Views
684

Downloads
592

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Jul 21, 2021
Published Nov 3, 2021
10.24018/ejmed.2021.3.6.985

Abstract viewed = 684 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

The seroprevalence in the population of 8 big cities (Ahmedabad, Jaipur, Bangalore, Pune, Coimbatore, Surat, Visakhapatnam, and Nagpur) of India and the dynamics of the COVID-19 spread have been compared. The seropositivity data are of the self-referred residents only. The research is useful to know if the seroprevalence that occurred in the population has decreased the surge in infection in the second wave of the pandemic. The seroprevalence data are for the period July-December 2020 while the monthly new infections have been studied for July 2020-June 2021. For the cities: Visakhapatnam, Nagpur, Surat, Pune, and Coimbatore, the seropositivity of the population reached a plateau and then decreased. A decrease in seroprevalence did not result in higher infection rates. The seropositivity of Jaipur, Ahmedabad, and Bangalore showed a monotonous increase. A relationship between the plateau values of seroprevalence and infection rates could be established. More seroprevalence resulted in lower infection rates in cities (Bangalore, Visakhapatnam, Jaipur) and (Surat, Coimbatore, Pune) in the second wave of COVID-19 pandemic. The investigation of seroprevalence in the population will help in ramping up vaccination to eradicate the pandemic.

Keywords: COVID-19 India, second pandemic wave, seropositivity, seroprevalence, spread dynamics

Downloads

Download data is not yet available.

References

  1. Coronavirus (COVID-19)-Google News (JHU CSSE COVID-19 DATA).
     Google Scholar
  2. Covid-19 not slowing down yet, Delta variant spreading rapidly:WHO’s chief scientist Dr. Soumya Swaminathan, Hindustan Times, July 9, 2021.
     Google Scholar
  3. COVID-19 Cases in India and World: Country and City wise corona cases list, Times of India (indiatimes.com).
     Google Scholar
  4. White House prepares for COVID-19 outbreaks due to highly contagious Delta variants, Reuters, July 2, 2021.
     Google Scholar
  5. S. Korea’s COVID-19 cases spike as Delta variant spreads, Reuters, July 2, 2021.
     Google Scholar
  6. ,733 new Covid cases, 930 deaths registered in India in 24 hours; recovery rate rises to 97.18%, The Times of India, July 7, 2021.
     Google Scholar
  7. India crosses the 3-crore mark in COVID-19 cases, lags behind in vaccinations, The Hindu, June 24, 2021.
     Google Scholar
  8. Number of fresh COVID-19 cases down but second wave not over yet: Ministry, The Hindu, July 6, 2021.
     Google Scholar
  9. Second Covid-19 wave lingering, or early signs of 3rd? Hindustan Times, July 9, 2021.
     Google Scholar
  10. Pfizer backs booster shots, US experts say no need yet, Hindustan Times, July 10, 2021.
     Google Scholar
  11. 'Caution folks': Top WHO scientist flags 'dangerous trend' of mixing Covid-19 vaccines, Times of India, July 12, 2021.
     Google Scholar
  12. Z. Shervani, D. Bhardwaj and R. Nikhat, “Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity,” European Journal of Medical and Health Sciences, 3(3): 38-41, 2021.
    DOI  |   Google Scholar
  13. Z. Shervani, “COVID-19 in Kerala: Health Index Theory,” European Journal of Medical and Health Sciences, 3(2), 21-24, 2021.
    DOI  |   Google Scholar
  14. Z. Shervani, “COVID-19 in Kerala: The Dynamics of Spread and Health Index Theory,” RAS Medical Science, 1(2), 1-3, 2021.
    DOI  |   Google Scholar
  15. Z. Shervani, I. Khan, N. Y. Siddiqui, T. Khan and U. Y. Qazi, “Viability of SARS-CoV-2 and Sanitization Methods,” European Journal of Medical and Health Sciences, 3(1): 22-27, 2021.
    DOI  |   Google Scholar
  16. Z. Shervani, I. Khan, N. Y. Siddiqui, T. Khan and U. Y. Qazi, “Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa,” European Journal of Medical and Health Sciences, 3(1): 34-38, 2021.
    DOI  |   Google Scholar
  17. Z. Shervani, I. Khan and U. Y. Qazi, “Sars-cov-2 delayed Tokyo 2020 olympics: Very recent advances in covid-19 detection, treatment, and vaccine development useful conducting the games in 2021,” Advances in Infectious Diseases, 10(3): 56-66, 2020.
    DOI  |   Google Scholar
  18. Z. Shervani, I. Khan and U. Y. Qazi, “COVID-19 vaccine,” Advances in Infectious Diseases, 10(3):195-210, 2020.
    DOI  |   Google Scholar
  19. Z. Shervani, I. Khan, T. Khan and U. Y. Qazi, “World’s fastest supercomputer picks COVID-19 drug,” Advances in Infectious Diseases, 10(3): 211-225, 2020.
    DOI  |   Google Scholar
  20. Z. Shervani, D.Bhardwaj and R. Nikhat, “COVID-19 Infection in India: Seropositivity versus the Dynamics of the Spread,” European Journal of Medical and Health Sciences, 3(4):95-99, 2021.
    DOI  |   Google Scholar
  21. A. Velumani, C. Nikam, W. Suraweera, S. H. Fu, H. Gelband, P. E. Brown and P. Jha, “SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020,” medRxiv 2021.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 > >>